Substances

4-MeO-PCP

4meopcp
4-MeO-PCP molecular scheme

An arylcyclohexamine dissociative anaesthetic related to PCP. First discovered in the 1960s by Parke-Davis, it was introduced to the RC market in 2008. Reported to be less potent than PCP. It is not commonly seen, but has seen some increase in popularity with the inavailability of other dissociatives.

Harm potential

moderately addictive with a high potential for abuse

Source: PsychonautWiki

Dosage

This dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

oral

light: 75-100mg

common: 100-170mg

strong: 170-250mg

insufflated

light: 30-75mg

common: 75-150mg

strong: 0-0mg

Source: PsychonautWiki

Effects

  • dizziness
  • Motor control loss
  • nausea
  • Perception of bodily lightness
  • Physical autonomy
  • Physical euphoria
  • Spatial disorientation
  • spontaneous bodily sensations
  • Physical disconnection
  • Tactile suppression
  • Optical sliding
  • amnesia
  • anxiety suppression
  • Cognitive disconnection
  • Compulsive redosing
  • conceptual thinking
  • Creativity enhancement
  • déjà vu
  • Depersonalization
  • Derealization
  • Disinhibition
  • Dream potentiation
  • Existential self-realization
  • Cognitive euphoria
  • memory suppression

Source: Tripsit.me

Tolerance

full

develops with prolonged and repeated use

half

3 - 7 days

zero

1 - 2 weeks

Source: PsychonautWiki

Download the App for in-depth drug analysis

Browse thousands of recent drug alerts and view factsheets for more than 200 substances in the KnowDrugs App!